4.5 Article

Spheroid-induced heterogeneity and plasticity of uveal melanoma cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Optimisation of the Chicken Chorioallantoic Membrane Assay in Uveal Melanoma Research

Ekaterina A. Sokolenko et al.

Summary: The treatment of uveal melanoma and its metastases poses a great challenge in the field of ocular oncology. Effective treatment strategies are still lacking. Researchers have optimized a chicken embryo assay as an in vivo model for testing novel therapies for uveal melanoma.

PHARMACEUTICS (2022)

Article Hematology

Adjuvant systemic treatment for high-risk resected non-cutaneous melanomas: What is the evidence?

Gonzalo Tapia Rico et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Article Cell Biology

ZEB1: New advances in fibrosis and cancer

Lin Cheng et al.

Summary: ZEB1, an important transcription factor, plays crucial roles in embryonic development, fibrosis, and tumor progression; Abnormal expression of ZEB1 may be associated with poor cancer prognosis; ZEB1 could potentially serve as a biomarker in fibrosis or cancer.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)

Review Pharmacology & Pharmacy

Vasculogenic mimicry, a complex and devious process favoring tumorigenesis-Interest in making it a therapeutic target

Lucas Treps et al.

Summary: Tumor cell vasculogenic mimicry (VM) is a plasticity phenomenon where aggressive cancer cells form de novo vascular networks, associated with malignant phenotype and poor clinical outcomes. Various molecular mechanisms and signal pathways participate in VM induction and formation, leading to the utilization of more VM-related strategies in anticancer treatment.

PHARMACOLOGY & THERAPEUTICS (2021)

Review Oncology

Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy

Tamir Baram et al.

Summary: Cellular heterogeneity in cancer is largely influenced by cancer cell plasticity, with inflammatory elements playing a crucial role in promoting tumor cell remodeling. Inflammation-associated myeloid cells, pro-inflammatory cytokines, and inflammatory chemokines are key factors driving forward key processes of tumor cell plasticity, including stemness/EMT, therapy resistance, and dormancy. Targeting inflammatory elements may have significant clinical benefits for cancer patients, as they are a common denominator shared by different aspects of tumor cell plasticity.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Narrative review: mesenchymal-epithelial transition inhibitors-meeting their target

Danish Safi et al.

Summary: Genetic alterations in MET are commonly found in solid tumors, especially in NSCLC. METex14 skip is a true oncogenic driver and targeted therapies have shown significant improvements in clinical outcomes. Resistance mechanisms and alterations in anti-tumor immunity through MET inhibition remain areas needing further exploration.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

Article Oncology

Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells

Gisella Perez et al.

Summary: This study demonstrated that stable silencing of ZEB1 in prostate cancer cell lines can reverse CSC properties, including decreased expression levels of CSC phenotype markers, reduced ability to form prostatospheres, and generate colonies. Targeting ZEB1 may be a key factor to eradicate CSCs and improve the prognosis of patients with advanced PCa.

ONCOLOGY REPORTS (2021)

Review Oncology

MiRNA-mediated EMT and CSCs in cancer chemoresistance

Bing Dong et al.

Summary: Cancer stem cells (CSCs) play a crucial role in tumorigenesis and cancer progression, with their generation believed to be driven by epithelial-to-mesenchymal transition (EMT). MicroRNAs (miRNAs) have been found to be key players in this process, and regulating miRNAs associated with EMT or CSCs may help overcome drug resistance.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

Article Genetics & Heredity

Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics

Luiz Paulo Chaves et al.

Summary: Prostate cancers may reactivate a latent embryonic program called the epithelial-mesenchymal transition (EMT) during the development of metastatic disease. Through EMT, tumors can develop a mesenchymal phenotype similar to cancer stem cell traits that contributes to metastasis and variation in therapeutic responses. Some of the recurrent somatic mutations of prostate cancer affect EMT driver genes and effector transcription factors.
Article Gastroenterology & Hepatology

Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling

Cindy Lobe et al.

Summary: The transcription factor ZEB1 plays a crucial role in the progression of cholangiocarcinoma by regulating the crosstalk between tumor cells and cancer-associated fibroblasts (CAFs), leading to tumor dedifferentiation and CAF activation. In vitro and in vivo experiments demonstrated that ZEB1 promotes epithelial-mesenchymal transition and stemness in tumor cells, as well as inducing myofibroblast proliferation through the upregulation of connective tissue growth factor (CTGF). The study also found that ZEB1 controls the expression of paracrine signals such as HGF and IL6 in both tumor cells and myofibroblasts.

HEPATOLOGY (2021)

Article Multidisciplinary Sciences

Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1

Huimin Jiang et al.

NATURE COMMUNICATIONS (2020)

Review Biotechnology & Applied Microbiology

Research Progress of Cancer Stem Cells in Uveal Melanoma

Yu Ning Chen et al.

ONCOTARGETS AND THERAPY (2020)

Article Multidisciplinary Sciences

ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression

Yao Chen et al.

SCIENTIFIC REPORTS (2017)

Article Medical Laboratory Technology

Uveal Melanoma: An Analysis of Cellular Features and Comparison to Monosomy 3 Status

Fatima Hamadeh et al.

DIAGNOSTIC CYTOPATHOLOGY (2016)

Article Biochemistry & Molecular Biology

The ZEB1 Transcription Factor Acts in a Negative Feedback Loop with miR200 Downstream of Ras and Rb1 to Regulate Bmi1 Expression

Yongqing Liu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Review Cell & Tissue Engineering

Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells

Erika Pastrana et al.

CELL STEM CELL (2011)

Review Biochemistry & Molecular Biology

MicroRNA therapeutics

J. A. Broderick et al.

GENE THERAPY (2011)

Article Ophthalmology

Uveal Melanoma Cell Lines Contain Stem-Like Cells That Self-Renew, Produce Differentiated Progeny, and Survive Chemotherapy

Helen Kalirai et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)

Article Biotechnology & Applied Microbiology

Identification of virus resistant tumor cell subpopulations in three-dimensional uveal melanoma cultures

K. Valyi-Nagy et al.

CANCER GENE THERAPY (2010)

Article Cell Biology

Therapeutic targeting of C-terminal binding protein in human cancer

Michael W. Straza et al.

CELL CYCLE (2010)

Editorial Material Oncology

The role of stem cell markers in multidrug resistance mediated by ABC transporters

Amit K. Tiwari et al.

LEUKEMIA RESEARCH (2010)

Article Oncology

Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells

Rihong Cong et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)

Article Developmental Biology

Zeb1 links epithelial-mesenchymal transition and cellular senescence

Yongqing Liu et al.

DEVELOPMENT (2008)

Article Ophthalmology

Authenticating Cell Lines in Ophthalmic Research Laboratories

Robert Folberg et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)